HSCS Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020
Period Ended	04/30/2023	04/30/2022	04/30/2021	04/30/2020
Operating Revenue	$5,150.00	$14,373.00	$25,604.00	$64,182.00
Cost of Revenue	$2,796.00	$7,890.00	$10,665.00	$46,460.00
Gross Profit	$2,354.00	$6,483.00	$14,939.00	$17,722.00
Gross Profit Ratio	0.46	0.45	0.58	0.28
Research and Development Expenses	$2.46 M	$3.00 M	$1.71 M	$2.04 M
General & Administrative Expenses	$0.00	$0.00	$0.00	$0.00
Selling & Marketing Expenses	$0.00	$0.00	$0.00	$0.00
Selling, General & Administrative Expenses	$3.65 M	$1.71 M	$874,620.00	$1.80 M
Other Expenses	$1,848.00	$2,558.00	-$3,451.00	$19,893.00
Operating Expenses	$6.12 M	$4.72 M	$2.58 M	$3.84 M
Cost And Expenses	$6.12 M	$4.72 M	$2.59 M	$3.88 M
Interest Income	$243,174.00	$371,619.00	$132,454.00	$2,811.00
Interest Expense	$243,174.00	$371,619.00	$132,454.00	$2,811.00
Depreciation & Amortization	$28,763.00	$29,124.00	$30,160.00	$83,720.00
EBITDA	-$6.08 M	-$4.68 M	-$2.54 M	-$3.73 M
EBITDA Ratio	-1181.4	-325.63	-99.12	-58.19
Operating Income	-$6.11 M	-$4.71 M	-$2.57 M	-$3.82 M
Operating Income Ratio	-1186.98	-327.66	-100.3	-59.49
Total Other Income/Expenses Net	-$241,326.00	-$118,861.00	$115,958.00	$7,066.00
Income Before Tax	-$6.35 M	-$4.83 M	-$2.45 M	-$3.81 M
Income Before Tax Ratio	-1233.84	-335.93	-95.77	-59.38
Income Tax Expense	$484.50 M	-$250,200.00	$129,003.00	$22,704.00
Net Income	-$490.85 M	-$4.58 M	-$2.58 M	-$3.83 M
Net Income Ratio	-95311.51	-318.52	-100.81	-59.73
EPS	-61.74	-0.0168	-0.32	-0.48
EPS Diluted	-61.74	-0.0168	-0.32	-0.48
Weighted Average Shares Out	$7.95 M	$271.80 M	$8.04 M	$8.04 M
Weighted Average Shares Out Diluted	$7.95 M	$271.80 M	$8.04 M	$8.04 M
Link

Heart Test Laboratories, Inc. (HSCS) Financials

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification